GE HealthCare, Medis Medical Imaging Collaborate To Focus On Non-Invasive Coronary Assessments To Help Advance Precision Care In Treatment Of Coronary Artery Disease
Author: Benzinga Newsdesk | May 14, 2024 09:01am
- Collaboration seeks to advance precision care by providing an alternative, non-invasive approach to the assessment of coronary physiology.
- Both companies will focus on the integration of Medis QFR into GE HealthCare's cath lab environment built around the Allia Platform to enable a seamless user experience.
Today, GE HealthCare (NASDAQ:GEHC), a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Medis Medical Imaging, a leading cardiac imaging software company, announced their collaboration aimed at helping advance precision care in the diagnosis and treatment of coronary artery disease (CAD). Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare's interventional cardiology portfolio built around the Allia Platform. The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians.
Posted In: GEHC
